RxVantage

RxVantage

Private
El Segundo, CaliforniaEnterprise Softwarehttps://www.rxvantage.com/

Last Round

VC Round

Jan 19, 2022

Total Funding Raised

$2.5M

Company Overview

RxVantage is a healthcare technology company that provides a digital platform connecting healthcare providers with educational resources and experts from life science companies.

Sector

Enterprise Software

Verticals

Vertical SaaS, Sales Enablement, CRM, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Non-AI

Keywords

healthcare scheduling platformpharma rep schedulingphysician access platformmedical practice softwaretwo-sided marketplacepharma sales enablementvendor credentialingvertical SaaSrules-based schedulingMSL engagementpatient assistance programsfreemium model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RxVantage Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RxVantage Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 19, 2022
Series ADec 31, 2011
SeedJun 1, 2009

Key People

Founding team and executive leadership

Jeremy Gilman

Co-Founder CMO

Founding Team

Tom Case

Chief Financial Officer

Executive Team

Bret Piano

Chief Product Officer

Executive Team

RxVantage Investors

Notable investors and investment history

InvestorRounds
dRx CapitalVC Round
Merck Global Health Innovation FundVC Round
McKesson VenturesVC Round
Spectrum EquityVC Round
Javelin Venture PartnersVC Round, Series A
Slater Technology FundSeries A, VC Round, Seed
Wavemaker PartnersSeries A

RxVantage Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RxVantage Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RxVantage's valuation, stock price, and market status.

Firmographic Details

HeadquartersEl Segundo, California
Employee Range166
Year Founded2007
Last FundingJan 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.